Category Specific RSS

Categories: News

Graphene coating kills E-Coli, Sparc Technologies testing identifies

One of the world’s most annoying forms of bacterial infection could soon see a decrease in prevalence with materials tech company Sparc Technologies (ASX: SPN) identifying antibacterial properties in graphene that kills E-Coli.

The testing was undertaken in collaboration with Flinders University in Adelaide where results indicated that an epoxy coating of graphene-based additives mostly eliminated the presence of Escherichia Coli (E-Coli). In one case, the testing evaluated complete destruction of the E-Coli bacteria in comparison to the same coating type containing no graphene.

“Once again, graphene is continuing to demonstrate its unique properties that impart significant improvements to the graphene applications that Sparc is developing,” said Sparc Technologies CEO, Mike Bartels.

“Following on from the very impressive results of earlier work achieved with anti-corrosive coatings, we are now seeing outstanding results with antimicrobial coatings, which encourages us to develop a product for a multitude of anti-microbial coatings applications in multi-billion dollar markets.”

Sparc has already identified the ability of graphene coating to substantially reduce natural corrosion on steel whereas this application has a more significant use case in every-day life. Such an ability to maximise antibacterial properties could be applied to surfaces prone to bacteria such as; hospitals, public areas, food preparation facilities, drinking water systems, antifouling for shipping, and coating for wastewater systems.

With these highly encouraging results, Sparc now intends to increase testing into other common bacterias and viruses.

When contracted, E-Coli infections commonly result in severe diarrhea, nausea and vomiting which can be life-threatening in infants and people with compromised immune systems.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

Control Bionics Moves to Fully Acquire NeuroBounce Program as EMG-Based Performance Tech Gains Momentum

As interest in neuromuscular activation tools accelerates across elite sport, Control Bionics Limited (ASX:CBL) is…

4 hours ago

SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition

Australia’s data-centre construction sector continues to surge on the back of cloud adoption, AI-driven computing…

2 weeks ago

Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards

A major Australian research initiative is set to push forward global understanding of brain injury,…

4 weeks ago

Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion

Following a successful FY25 which saw a boost in gross profit after launching its refurbished…

1 month ago

Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program

Pivotal Metals (ASX:PVT) has locked in $5.4 million in fresh funding to accelerate exploration across…

1 month ago

Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise

Biotech company Biotron Limited (ASX:BIT) has announced a bold step into the anaesthetics sector, acquiring…

2 months ago